secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2026-02-20T23:59:59+00:00
Accession:  0001829126-26-001534
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

KALA Bio director David Lazar resigns from board effective February 16, 2026
----------------------------------------------------------------------------

- David Lazar resigned as a member of the Board of Directors of KALA Bio on February 16, 2026.
- Resignation was effective immediately and not due to any disagreement with the company.
- No replacement for Lazar's board seat has been announced in this filing.
- The company filed the 8-K on February 20, 2026, reflecting the departure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626001534/0001829126-26-001534-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626001534/kalabio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-001534

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer